SCHEMBL19980358

SCHEMBL19980358

Clc1ccc2c3c(cccc13)N(c1cccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)c1)c1ccccc1-2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.42
MEN1 O00255 7/20 0.42
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 5/20 0.42
HPGD P15428 5/20 0.36
MAPT P10636 5/20 0.36
LMNA P02545 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ADORA1 P30542 1/20 0.33
PLAUR Q03405 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
TET2 Q6N021 1/20 0.33
TET1 Q8NFU7 1/20 0.33
PDE6D O43924 1/20 0.33
CYP1A2 P05177 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
POLB P06746 1/20 0.33
ERCC1 P07992 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30343468 0.85 HPGD (0.42) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL19974401 0.85 HPGD (0.42) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL21115573 0.82 GRM5 (0.38) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL30607082 0.82 KMT2A (0.46) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL18810942 0.82 KMT2A (0.46) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL18624534 0.80 KDM4E (0.40) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL19980357 0.78 GRM5 (0.42) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL18624532 0.77 MEN1 (0.40) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL16884806 0.76 MEN1 (0.41) KMT2AMEN1ALDH1A1KDM4EHPGD
SCHEMBL24254086 0.76 PDE6D (0.43) KMT2AMEN1ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512841-B1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2023-04-26 EP disclosed
US-11447464-B2 Compounds with spirobifluorene-structures MERCK PATENT GMBH (DE) 2022-09-20 US disclosed
US-20190194164-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2019-06-27 US disclosed
WO-2018050584-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11447464-B2 Compounds with spirobifluorene-structures SLCO1B3, SLCO4C1, SLCO1B1 KMT2A 3037/4885MEN1 1205/4885ALDH1A1 380/4885
US-20190194164-A1 COMPOUNDS WITH SPIROBIFLUORENE-STRUCTURES SLCO1B3, SLCO4C1, SLCO1B1 KMT2A 3037/4885MEN1 1205/4885ALDH1A1 380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.